Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (69) Arrow Down
Filter Results: (69) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (130)
    • People  (1)
    • News  (41)
    • Research  (69)
    • Multimedia  (1)
  • Faculty Publications  (15)

Show Results For

  • All HBS Web  (130)
    • People  (1)
    • News  (41)
    • Research  (69)
    • Multimedia  (1)
  • Faculty Publications  (15)
← Page 2 of 69 Results →
Sort by

Are you looking for?

→Search All HBS Web
  • March 2008
  • Case

Novartis AG: Science-Based Business

By: H. Kent Bowen and Courtney Purrington
Novartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in 2007. Pharmaceuticals account for slightly over $24B of that total. In 2007,... View Details
Keywords: Innovation and Invention; Resource Allocation; Product Development; Partners and Partnerships; Research and Development; Science-Based Business; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Bowen, H. Kent, and Courtney Purrington. "Novartis AG: Science-Based Business." Harvard Business School Case 608-136, March 2008.
  • 11 Aug 2003
  • Research & Ideas

Cheap, Fast, and In Control: How Tech Aids Innovation

experimentation and are triggering fundamental changes in R&D processes and performance in such fields as integrated circuit design, automotive development, and pharmaceutical drug discovery. Computer modeling and simulation, rapid... View Details
Keywords: by Wendy Guild
  • 24 Sep 2007
  • Research & Ideas

The FDA: What Will the Next 100 Years Bring?

The U.S. Food and Drug Administration, which was created by the passage of the 1906 Federal Food and Drugs Act, regulates companies and industries accounting for one-quarter of all consumer spending, roughly... View Details
Keywords: by Sean Silverthorne; Biotechnology; Consumer Products; Food & Beverage; Health
  • Research Summary

Health-care Applications

Active postmarketing drug surveillance.  There is substantial interest within the U.S. health community and among health policymakers in developing a surveillance system that scans public health databases in order to proactively detect potential drug safety... View Details

  • 05 Sep 2023
  • Book

Failing Well: How Your ‘Intelligent Failure’ Unlocks Your Full Potential

In the 1990s, after drugmaker Eli Lilly spent more than a decade and millions of dollars developing the new drug Alimta to treat lung cancer, the medication came up short in effectively treating cancer in expanded trials. While the... View Details
Keywords: by Michael Blanding
  • 22 Apr 2008
  • First Look

First Look: April 22, 2008

Business Harvard Business School Case 608-136 Novartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in... View Details
Keywords: Martha Lagace
  • 10 Oct 2007
  • First Look

First Look: First Look: October 10

purchases the same customers make when shopping without a coupon. The standard permanent income or lifecycle theory of consumption predicts that grocery spending will be unaffected by the use of a $10-off coupon, while a simple mental... View Details
Keywords: Martha Lagace
  • 19 Dec 2017
  • First Look

New Research and Ideas, December 19, 2017

is likely to have a meaningful effect on health care spending patterns. In addition, precision medicines can change the expected profitability of therapies both by allowing more sophisticated pricing systems and potentially decreasing the... View Details
Keywords: Carmen Nobel
  • 02 Mar 2007
  • What Do You Think?

What Is the Government’s Role in US Health Care?

Newman), the high cost of new technology, artificial restrictions on the supply of drugs (Sergey Mirkiin) and healthcare providers (David Stahl and Michael Robbins), the size and complexity of the problem itself (James Sullivan),... View Details
Keywords: by Jim Heskett; Health
  • 31 Mar 2023
  • Research & Ideas

Can a ‘Basic Bundle’ of Health Insurance Cure Coverage Gaps and Spur Innovation?

policies that amount to a “fragmented insurance system” that leaves 10 percent of the population uninsured, according to research by Harvard Business School Professor Amitabh Chandra. “The United States spends substantially more on health... View Details
Keywords: by Kasandra Brabaw; Insurance; Health
  • 05 Jul 2006
  • Research & Ideas

The Accidental Innovator

Companies spend many hundreds of billions of dollars on R&D each year, but the microwave oven was conceived from a melted candy bar, saccharin from an accidental chemical spill, and the Daguerre photo process via a shattered... View Details
Keywords: by Sarah Jane Gilbert
  • 21 Sep 2022
  • Research & Ideas

You Don’t Have to Quit Your Job to Find More Meaning in Life

you spend your life doing activities most people find senseless—such as copying the dictionary or collecting rubber bands? Do people still think your life is meaningful? “Impact can be subjective,” De Freitas points out. “You may feel... View Details
Keywords: by Shalene Gupta
  • 13 Jul 2020
  • Research & Ideas

Merck CEO Ken Frazier Discusses a COVID Cure, Racism, and Why Leaders Need to Walk the Talk

gives away a drug called Mectizan for river blindness. That's one pill per person per year. And we found it's really hard to get that the last mile to the people who really need it. Okay? So I would say there are two big issues with... View Details
Keywords: by Staff; Pharmaceutical
  • 19 Sep 2016
  • Research & Ideas

Why Isn't Business Research More Relevant to Business Practitioners?

disciplines, where academic research is leading to the development of a second skin that could improve drug delivery or alerting farmers and scientists on how to reduce nitrous oxide emissions from agricultural farming. Harvard Business... View Details
Keywords: by Carmen Nobel; Education
  • 07 Aug 2000
  • Research & Ideas

The Business of Biotech

coming of age of biotechnology. The disappearance of "blockbuster" drugs could create new management challenges for pharmaceutical companies. — Gary Pisano The prospect is exhilarating, but the road to this brave new biotech... View Details
Keywords: by Julia Hanna; Biotechnology; Health; Technology
  • 20 Nov 2006
  • Research & Ideas

Open Source Science: A New Model for Innovation

problems that were posted? A: Innovations happen at the intersection of disciplines. People have talked about that a lot and I think we're providing some systematic evidence now with this study. Another example is that a pharmaceutical company got unusual toxicology... View Details
Keywords: by Martha Lagace
  • 18 Nov 2014
  • First Look

First Look: November 18

television advertising influences online shopping. We construct a massive dataset spanning $3.4 billion in spending by 20 brands, including measures of brands' website traffic and transactions as well as ad content measures for 1,224... View Details
Keywords: Sean Silverthorne
  • 08 Dec 2003
  • Research & Ideas

Why Europe Lags in Pharmaceuticals and Biotech

the preferred testing ground for Phase 1 clinical trials of new drugs, the benefits of massive R&D spending and economic throw-offs are being enjoyed elsewhere, primarily in the United States and in an increasingly competitive Asia.... View Details
Keywords: by Sean Silverthorne; Biotechnology; Health; Pharmaceutical; Technology
  • 03 Oct 2006
  • First Look

First Look: October 3, 2006

considering selling its royalty interest in Enbrel, Amgen's blockbuster drug for the treatment of rheumatoid arthritis. In assessing whether to sell, and at what price, the hospital must determine its value to a potential buyer as well as... View Details
Keywords: Sean Silverthorne
  • 31 Oct 2004
  • Research & Ideas

Bypass Marketing: Are Docs Influenced?

Until the close of the last decade, health consumers received much of their knowledge and advice about prescription drugs from their physicians or other health care professionals. Today, pharmaceutical companies are View Details
Keywords: by Manda Salls
  • ←
  • 1
  • 2
  • 3
  • 4
  • →

Are you looking for?

→Search All HBS Web
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.